CO6400226A2 - Micrólido anti-inflamatorio - Google Patents
Micrólido anti-inflamatorioInfo
- Publication number
- CO6400226A2 CO6400226A2 CO11095916A CO11095916A CO6400226A2 CO 6400226 A2 CO6400226 A2 CO 6400226A2 CO 11095916 A CO11095916 A CO 11095916A CO 11095916 A CO11095916 A CO 11095916A CO 6400226 A2 CO6400226 A2 CO 6400226A2
- Authority
- CO
- Colombia
- Prior art keywords
- inflammatory
- microlid
- compound
- diethylaminoethanyl
- homoerythromycin
- Prior art date
Links
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- -1 2-diethylaminoethanyl Chemical group 0.000 abstract 1
- 229940126214 compound 3 Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000000440 neutrophil Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
El compuesto 3'-N-desmetil-4"-O-(2-dietilaminoetanoil)-6-O-metil-9a-aza-9a-homoeritromicina A, que tiene la Fórmula (I):o una sal del mismo, composiciones que comprenden el compuesto, su uso en el tratamiento de enfermedades inflamatorias dominadas por neutrófilos, y métodos para su preparación.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14860909P | 2009-01-30 | 2009-01-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6400226A2 true CO6400226A2 (es) | 2012-03-15 |
Family
ID=41698466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO11095916A CO6400226A2 (es) | 2009-01-30 | 2011-07-29 | Micrólido anti-inflamatorio |
Country Status (23)
Country | Link |
---|---|
US (1) | US8227428B2 (es) |
EP (1) | EP2384333B1 (es) |
JP (1) | JP5437394B2 (es) |
KR (1) | KR20110099791A (es) |
CN (1) | CN102378763A (es) |
AR (1) | AR075340A1 (es) |
AU (1) | AU2010209732B2 (es) |
BR (1) | BRPI1006114A2 (es) |
CA (1) | CA2748847A1 (es) |
CL (1) | CL2011001829A1 (es) |
CO (1) | CO6400226A2 (es) |
DO (1) | DOP2011000242A (es) |
EA (1) | EA201101139A1 (es) |
ES (1) | ES2412059T3 (es) |
IL (1) | IL213871A0 (es) |
MA (1) | MA32997B1 (es) |
MX (1) | MX2011008074A (es) |
PE (1) | PE20120220A1 (es) |
SG (1) | SG172782A1 (es) |
TW (1) | TW201038277A (es) |
UY (1) | UY32408A (es) |
WO (1) | WO2010086349A1 (es) |
ZA (1) | ZA201104653B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006087644A2 (en) | 2005-01-13 | 2006-08-24 | Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. | Macrolides with anti-inflammatory activity |
SG172782A1 (en) | 2009-01-30 | 2011-08-29 | Glaxo Group Ltd | Anti-inflammatory macrolide |
US20130045939A1 (en) * | 2010-03-19 | 2013-02-21 | Catabasis Pharmaceuticals, Inc. | Fatty acid macrolide derivatives and their uses |
WO2011131749A1 (en) * | 2010-04-23 | 2011-10-27 | Glaxo Group Limited | New 14 and 15 membered macrolides for the treatment of neutrophil dominated inflammatory diseases |
JP6116206B2 (ja) * | 2012-11-26 | 2017-04-19 | クリニプロ株式会社 | 吸入用パウダーの製造方法 |
CN110300596A (zh) * | 2017-01-13 | 2019-10-01 | 东菱药品工业株式会社 | 嗜中性粒细胞活化调节剂 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US525051A (en) | 1894-08-28 | Adjustable chair | ||
US3725385A (en) | 1970-11-02 | 1973-04-03 | Abbott Lab | Process for the demethylation of 3-amino macrolides |
EP0126344A2 (en) | 1983-05-20 | 1984-11-28 | Abbott Laboratories | Tripeptide esters of therapeutic agents |
OA08732A (fr) * | 1987-05-06 | 1989-03-31 | Adir | Nouveaux dérivés macrolides, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
SI9011409A (en) | 1990-07-18 | 1995-10-31 | Pliva Pharm & Chem Works | O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them |
EP0895999A1 (en) | 1997-08-06 | 1999-02-10 | Pfizer Products Inc. | C-4" substituted macrolide antibiotics |
HRP980189B1 (en) | 1998-04-06 | 2004-04-30 | Pliva Pharm & Chem Works | Novel 15-membered lactams ketolides |
AU772283B2 (en) * | 1999-05-18 | 2004-04-22 | Pfizer Products Inc. | Novel crystalline forms of a macrolide antibiotic |
HRP20010301A2 (en) | 2001-04-27 | 2001-12-31 | Pliva D D | New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases |
JP4790263B2 (ja) | 2002-07-08 | 2011-10-12 | グラクソ グループ リミテッド | 炎症性の疾患および病態を治療する新規な化合物、組成物および方法 |
ITMI20021726A1 (it) | 2002-08-01 | 2004-02-02 | Zambon Spa | Macrolidi ad attivita' antiinfiammatoria. |
GB0310986D0 (en) | 2003-05-13 | 2003-06-18 | Glaxo Group Ltd | Novel compounds |
DE602006004555D1 (de) | 2005-01-13 | 2009-02-12 | Glaxosmithkline Zagreb | Decladinosyl-macrolide mit entzündungshemmender wirkung |
WO2006087644A2 (en) * | 2005-01-13 | 2006-08-24 | Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. | Macrolides with anti-inflammatory activity |
JP5065910B2 (ja) | 2005-01-14 | 2012-11-07 | グラクソ グループ リミテッド | ビオチンおよび光親和性基を含む、マクロライド標的同定用のマクロライド化合物 |
SG172782A1 (en) | 2009-01-30 | 2011-08-29 | Glaxo Group Ltd | Anti-inflammatory macrolide |
-
2010
- 2010-01-28 SG SG2011046216A patent/SG172782A1/en unknown
- 2010-01-28 MX MX2011008074A patent/MX2011008074A/es active IP Right Grant
- 2010-01-28 KR KR1020117017844A patent/KR20110099791A/ko not_active Application Discontinuation
- 2010-01-28 CA CA2748847A patent/CA2748847A1/en not_active Abandoned
- 2010-01-28 ES ES10701369T patent/ES2412059T3/es active Active
- 2010-01-28 EP EP10701369.0A patent/EP2384333B1/en active Active
- 2010-01-28 WO PCT/EP2010/050967 patent/WO2010086349A1/en active Application Filing
- 2010-01-28 CN CN2010800149961A patent/CN102378763A/zh active Pending
- 2010-01-28 AU AU2010209732A patent/AU2010209732B2/en not_active Expired - Fee Related
- 2010-01-28 EA EA201101139A patent/EA201101139A1/ru unknown
- 2010-01-28 PE PE2011001406A patent/PE20120220A1/es not_active Application Discontinuation
- 2010-01-28 AR ARP100100227A patent/AR075340A1/es not_active Application Discontinuation
- 2010-01-28 US US12/695,272 patent/US8227428B2/en not_active Expired - Fee Related
- 2010-01-28 TW TW099102336A patent/TW201038277A/zh unknown
- 2010-01-28 MA MA34057A patent/MA32997B1/fr unknown
- 2010-01-28 UY UY0001032408A patent/UY32408A/es unknown
- 2010-01-28 BR BRPI1006114A patent/BRPI1006114A2/pt not_active IP Right Cessation
- 2010-01-28 JP JP2011546833A patent/JP5437394B2/ja not_active Expired - Fee Related
-
2011
- 2011-06-23 ZA ZA2011/04653A patent/ZA201104653B/en unknown
- 2011-06-30 IL IL213871A patent/IL213871A0/en unknown
- 2011-07-26 DO DO2011000242A patent/DOP2011000242A/es unknown
- 2011-07-28 CL CL2011001829A patent/CL2011001829A1/es unknown
- 2011-07-29 CO CO11095916A patent/CO6400226A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2748847A1 (en) | 2010-08-05 |
MA32997B1 (fr) | 2012-01-02 |
EP2384333A1 (en) | 2011-11-09 |
MX2011008074A (es) | 2011-08-17 |
BRPI1006114A2 (pt) | 2018-02-06 |
JP5437394B2 (ja) | 2014-03-12 |
ES2412059T3 (es) | 2013-07-10 |
CL2011001829A1 (es) | 2011-10-14 |
EA201101139A1 (ru) | 2012-03-30 |
AU2010209732B2 (en) | 2012-12-20 |
UY32408A (es) | 2010-07-30 |
AR075340A1 (es) | 2011-03-23 |
EP2384333B1 (en) | 2013-04-17 |
SG172782A1 (en) | 2011-08-29 |
IL213871A0 (en) | 2011-07-31 |
DOP2011000242A (es) | 2011-09-15 |
ZA201104653B (en) | 2012-02-29 |
CN102378763A (zh) | 2012-03-14 |
KR20110099791A (ko) | 2011-09-08 |
PE20120220A1 (es) | 2012-04-04 |
US20100197623A1 (en) | 2010-08-05 |
JP2012516304A (ja) | 2012-07-19 |
AU2010209732A1 (en) | 2011-07-21 |
WO2010086349A1 (en) | 2010-08-05 |
TW201038277A (en) | 2010-11-01 |
US8227428B2 (en) | 2012-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR077629A1 (es) | Mimetico de smac | |
PA8772101A1 (es) | Imidazol-triazolopirimidinas sustituidas | |
GT201400111A (es) | Triazolopiridinas sustituidas | |
CR20150075A (es) | Nuevo derivado de cumarina que tiene efecto antitumoral | |
CR20130560A (es) | Compuestos de bezotiazol y su uso farmacéutico | |
UY32062A (es) | Inhibidores de beta-secretasa | |
CL2011000558A1 (es) | Formas cristalinas de un compuesto derivado de 2-tiazolil-4-quinolinil-oxi; sal de sodio del compuesto, composicion farmaceutica que comprende la sal de sodio, util para tratar una infeccion por el virus de la hepatitis c. | |
GT200500360A (es) | Compuestos organicos | |
CR20120264A (es) | Compuestos | |
CO6280490A2 (es) | 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso | |
GT200900095A (es) | Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas. | |
CL2011002849A1 (es) | Composicion anti-inflamatoria que comprende microorganismos sometidos a tratamiento a por lo menos 71,5 grados celsius durante por lo menos 1 segundo; uso de una composicion para tratar o prevenir padecimientos inflamatorios; metodos para proporcionar los microorganismos. | |
ECSP12011935A (es) | Triazolopiridinas | |
GT200900230A (es) | 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso | |
NI200800294A (es) | Nueva forma cristalina vi de la agomelatina, su procedimiento de preparacion y las composiciones farmacéuticas que la contienen. | |
CL2010000188A1 (es) | Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso. | |
UY30846A1 (es) | Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos | |
AR110128A2 (es) | Compuesto del grupo de las 3-(imidazoil)-pirazolo[3,4-b]piridinas, composición farmacéutica que lo comprende y método para preparar el mismo | |
DOP2009000287A (es) | Oxazolidinonas sustituidas y su uso | |
CU20120171A7 (es) | Triazolopiridinas sustituidas | |
AR079050A1 (es) | Compuestos benzoimidazolicos y sus usos | |
CO6400226A2 (es) | Micrólido anti-inflamatorio | |
UY31133A1 (es) | "oxazolidinonas sustituidas y su uso" | |
AR090806A1 (es) | Glucosidos de pirazol y su utilizacion en el tratamiento de la diabetes tipo i y ii | |
PA8806501A1 (es) | Triazolotriazinas y triazolopirazinas y su uso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |